AstraZeneca Pharma India appoints three Senior Management Personnel
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
AstraZeneca Pharma India has appointed two new Senior Management Personnel and promoted one internal leader, effective August 1 and September 1, 2026. Mihir Parikh joins as Director for Commercial Excellence, Business Development and Strategy. Vinay Sharma is promoted internally to Director for the Rare Diseases Business Unit. Amay Ashok Pandey is appointed as Director for the Oncology Business Unit. All three are full-time roles approved by the Board on recommendation of the Nomination and Remuneration Committee.
Routine senior management reshuffle with no major governance changes; reflects continued investment in oncology and rare disease verticals.